DXT — Dexterra Income Statement
0.000.00%
- CA$503.57m
- CA$589.09m
- CA$1.00bn
- 90
- 82
- 93
- 99
Annual income statement for Dexterra, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 471 | 733 | 972 | 928 | 1,003 |
Cost of Revenue | |||||
Gross Profit | 60 | 102 | 103 | 141 | 160 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 391 | 697 | 961 | 869 | 936 |
Operating Profit | 80.6 | 36 | 10.1 | 59 | 67.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 76.7 | 33.3 | 3.22 | 47.5 | 53.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 64.5 | 24.6 | 3.71 | 35.8 | 37.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 64 | 24.4 | 3.43 | 26.6 | 19.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 64 | 24.4 | 3.43 | 26.6 | 19.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.119 | 0.286 | 0.199 | 0.655 | 0.58 |
Dividends per Share |